Сlinical and molecular aspects of helicobacter pylori resistance to antimicrobial drugs
The literature review tells about current views on the clinical and molecular aspects of antibiotic resistance of Helicobacter pylori (H. pylori). Today, the growing number of H. pylori strains resistant to the first-line regimens is considered to be the main reason of treatment failure. In the tot...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2013-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1116 |
| _version_ | 1797842132628668416 |
|---|---|
| author | Y. A. Kucheryaviy D. M. Andreyev E. V. Barkalova |
| author_facet | Y. A. Kucheryaviy D. M. Andreyev E. V. Barkalova |
| author_sort | Y. A. Kucheryaviy |
| collection | DOAJ |
| description | The literature review tells about current views on the clinical and molecular aspects of antibiotic resistance of Helicobacter pylori (H. pylori). Today, the growing number of H. pylori strains resistant to the first-line regimens is considered to be the main reason of treatment failure. In the total global population, incidence of drug-resistant strains of H. pylori varies greatly across different geographic areas and correlates with the total frequency of antibiotics intake by the corresponding population. Latest global consensus recommendations regulate a differential choice strategy in selecting eradication therapy. The choice should take into account the level of resistance of H. pylori to clarithromycin, as this type of resistance has greatest clinical significance. |
| first_indexed | 2024-04-09T16:42:51Z |
| format | Article |
| id | doaj.art-e005bd5dc49445969933906e6878b557 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:42:51Z |
| publishDate | 2013-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-e005bd5dc49445969933906e6878b5572023-04-23T06:56:37ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902013-12-01010111510.21518/2079-701X-2013-10-11-151116Сlinical and molecular aspects of helicobacter pylori resistance to antimicrobial drugsY. A. Kucheryaviy0D. M. Andreyev1E. V. Barkalova2Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Russian Ministry of HealthMoscow State University of Medicine and Dentistry named after A.I. Evdokimov, Russian Ministry of HealthMoscow State University of Medicine and Dentistry named after A.I. Evdokimov, Russian Ministry of HealthThe literature review tells about current views on the clinical and molecular aspects of antibiotic resistance of Helicobacter pylori (H. pylori). Today, the growing number of H. pylori strains resistant to the first-line regimens is considered to be the main reason of treatment failure. In the total global population, incidence of drug-resistant strains of H. pylori varies greatly across different geographic areas and correlates with the total frequency of antibiotics intake by the corresponding population. Latest global consensus recommendations regulate a differential choice strategy in selecting eradication therapy. The choice should take into account the level of resistance of H. pylori to clarithromycin, as this type of resistance has greatest clinical significance.https://www.med-sovet.pro/jour/article/view/1116helicobacter pyloriэрадикацияантибиотикорезистентностькларитромицинметронидазоламоксициллинтетрациклинлевофлоксацинрифабутинфуразолидонhelicobacter pylorieradicationmetronidazoleamoxicillintetracyclinelevofloxacinrifabutinfurazolidone |
| spellingShingle | Y. A. Kucheryaviy D. M. Andreyev E. V. Barkalova Сlinical and molecular aspects of helicobacter pylori resistance to antimicrobial drugs Медицинский совет helicobacter pylori эрадикация антибиотикорезистентность кларитромицин метронидазол амоксициллин тетрациклин левофлоксацин рифабутин фуразолидон helicobacter pylori eradication metronidazole amoxicillin tetracycline levofloxacin rifabutin furazolidone |
| title | Сlinical and molecular aspects of helicobacter pylori resistance to antimicrobial drugs |
| title_full | Сlinical and molecular aspects of helicobacter pylori resistance to antimicrobial drugs |
| title_fullStr | Сlinical and molecular aspects of helicobacter pylori resistance to antimicrobial drugs |
| title_full_unstemmed | Сlinical and molecular aspects of helicobacter pylori resistance to antimicrobial drugs |
| title_short | Сlinical and molecular aspects of helicobacter pylori resistance to antimicrobial drugs |
| title_sort | сlinical and molecular aspects of helicobacter pylori resistance to antimicrobial drugs |
| topic | helicobacter pylori эрадикация антибиотикорезистентность кларитромицин метронидазол амоксициллин тетрациклин левофлоксацин рифабутин фуразолидон helicobacter pylori eradication metronidazole amoxicillin tetracycline levofloxacin rifabutin furazolidone |
| url | https://www.med-sovet.pro/jour/article/view/1116 |
| work_keys_str_mv | AT yakucheryaviy slinicalandmolecularaspectsofhelicobacterpyloriresistancetoantimicrobialdrugs AT dmandreyev slinicalandmolecularaspectsofhelicobacterpyloriresistancetoantimicrobialdrugs AT evbarkalova slinicalandmolecularaspectsofhelicobacterpyloriresistancetoantimicrobialdrugs |